Cargando…
Prevention of COPD exacerbations: medications and other controversies
Exacerbations have significant impact on the morbidity and mortality of patients with chronic obstructive pulmonary disease. Most guidelines emphasise prevention of exacerbations by treatment with long-acting bronchodilators and/or anti-inflammatory drugs. Whereas most of this treatment is evidence-...
Autores principales: | Vestbo, Jørgen, Lange, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Respiratory Society
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5005132/ https://www.ncbi.nlm.nih.gov/pubmed/27730132 http://dx.doi.org/10.1183/23120541.00011-2015 |
Ejemplares similares
-
Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis
por: Mathioudakis, Alexander G., et al.
Publicado: (2017) -
A systematic evaluation of the diagnostic criteria for COPD and exacerbations used in randomised controlled trials on the management of COPD exacerbations
por: Mathioudakis, Alexander G., et al.
Publicado: (2019) -
Factors associated with change in exacerbation frequency in COPD
por: Donaldson, Gavin C, et al.
Publicado: (2013) -
Inhaled corticosteroid use by exacerbations and eosinophils: a real-world COPD population
por: Vestbo, Jørgen, et al.
Publicado: (2019) -
Outcomes reported on the management of COPD exacerbations: a systematic survey of randomised controlled trials
por: Mathioudakis, Alexander G., et al.
Publicado: (2019)